Pyrazolone derivatives as PDE4 inhibitors
View Patent ↗The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is a novel effective inhibitor of the type 4 phosphodiesterase.
1. 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-l-yl}-2-oxoethyl)pyrrolidine-2,5-dione.
2. A pharmaceutical composition comprising the compound according to claim 1 together with at least one pharmaceutically acceptable auxiliary.
3. A method for inhibiting type 4 phosphodiesterase in a patient comprising administering to a patient in need thereof the compound according to claim 1 .
4. A method for treating diabetes mellitus in a patient comprising administering to a patient in need thereof the compound according to claim 1 .
5. A method for treating diabetes mellitus type II in a patient comprising administering to a patient in need thereof the compound according to claim 1 .